In a statement on Tuesday, RadioShack-Nissan management confirmed that it had withdrawn Fränk Schleck from the Tour de France following his Adverse Analytical Finding for the banned diuretic Xipamide.
“Our team attaches great value to transparency,” read the statement.
“Even though an abnormal ‘A Sample’ does not require these measures, Mr. Schleck and the team believe this is the right thing to do, to ensure the Tour de France can go on in calm and that Fränk Schleck can prepare his defense in accordance with the legal timing to do so.”
The team also addressed the substance found in Schleck’s July 14 sample, claiming that team doctors do not use Xipamide:
“On the subject of Xipamide the team can declare the following: it is not a product that is present in any of the medicine that the team uses and the reason for the presence of Xipamide in the urine sample of Mr. Schleck is unclear to the team. Therefore, the team is not able to explain the adverse findings at this point.
“However, the team is fully determined to collaborate with the anti-doping agencies in order to resolve the matter.”